Walking forward: The South Dakota Native American Project

Journal of Cancer Education

Volumn 20, Issue SUPPL. 1, 2005, Pages 65-70

  Petereit, Daniel G ^a,b   Rogers, Deborah ^a   Burhansstipanov, Linda ^f   Kaur, Judith ^c   Govern, Frank ^d   Howard, Steve P ^b   Osburn, Christen H ^e   Coleman, C Norman ^d   Fowler, Jack F ^b   Chappell, Richard ^b   Mehta, Minesh P ^b  

^a RAPID CITY REGIONAL HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c MAYO CLINIC CANCER CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e SAIC FREDERICK INC   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ATM PROTEIN;

ADVANCED CANCER; AMERICAN INDIAN; BRACHYTHERAPY; BREAST CANCER; CANCER CENTER; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; CULTURAL ANTHROPOLOGY; DISEASE COURSE; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HYPOTHESIS; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION SICKNESS; REVIEW; UNITED STATES; URBAN POPULATION;

BREAST NEOPLASMS; CLINICAL TRIALS; COMMUNITY-INSTITUTIONAL RELATIONS; CONSUMER PARTICIPATION; CULTURAL CHARACTERISTICS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INDIANS, NORTH AMERICAN; MALE; PROGRAM DEVELOPMENT; PROSTATIC NEOPLASMS; QUALITY OF HEALTH CARE; RURAL POPULATION; SOUTH DAKOTA; URBAN POPULATION;

EID: 21044443576     PISSN: 08858195     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15430154jce2001s_14     Document Type: Review

References (29)

1. Bobinski MA. Health disparities and the law: wrongs in search of a right. Am J Law Med. 2003;29:363-380.
2. Geiger HJ. Racial and ethnic disparities in diagnosis and treatment: A review of the evidence and a consideration of causes. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2003:415-454
3. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109-2117.
4. Haynes MA, Smedley BD. The Unequal Burden of Cancer: An Assessment of NlH Research and Programs for Ethnic Minorities and the Medically Underserved. Washington, DC: National Academy Press; 1999:338
5. Petereit DG, Rogers D, Helbig P, et al. Geographic distance from the cancer center may be a treatment barrier for American Indians undergoing radiotherapy. Paper presented at: Intercultural Cancer Council 9th Biennial Symposium on Minorities, the Medically Underserved and Cancer; March 27, 2004; Washington, DC.
6. Burhansstipanov L, Hollow W. Native American cultural aspects of nursing oncology care. Semin Oncol Nurs. 2001;17:206-219.
7. Burhansstipanov L, Olsen S. Cancer prevention and early detection in American Indian and Alaska Native populations. In: Frank-Stromborg M, Olsen S, eds. Cancer Prevention in Diverse Populations: Cultural Implications for the Multi-disciplinary Team. Pittsburgh, PA: Oncology Nursing Society; 2001:3-52.
8. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
9. Sorenson G, Emmons K, Hunt MK, et al. Model for incorporating social context in health behavior interventions: application for cancer prevention for working-class, multiethnic populations. Prev Med. 2003;37:188-197.
10. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097-1105.
11. Brenner DJ, Hall EJ. Fractionation and protraction of radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:1095-1101.
12. Duchesne GM, Peters LJ. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-hose-rate brachytherapy. Int J Radiat Oncol Biol Phvs. 1999;44:747-748.
13. Zelefsky MJ, Wallner KE, Ling CC, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent Iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol. 1999;17:517-522.
14. Blasko JC, Mate T, Sylvester JE, et al. Brachytherapy for carcinoma of the prostatet techniques, patient selection, and clinical outcomes. Semin Radiat Oncol. 2002;12:81-94.
15. Kestin LL, Martinez AA, Stromberg JS, et al. Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol. 2000;18:2869-2880.
16. Mate TP, Gottesman JE, Hatton J, et al. High dose-rate after loading 192iridium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys. 1998;41:525-533.
17. Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin. 2002;52:154-179.
18. Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254-2262.
19. Wennberg JE. Breast sparing surgery. In: Cooper, MM, ed. The Dartmouth Atlas of Health Care. Chicago, IL: American Hospital Publishing; 1996:128-129.
20. Vicini FA, Kaglan KL, Kestin LL. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19:1993-2001.
21. King TA, Bolton JS, Kuske RR. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is, 1, 2) breast cancer. Am J Surg Pathol. 2000;180:299-304.
22. Kuske RR, Winter K, Arthur D. A phase II trial of brachytherapy alone following lumpectomy for select breast cancer: toxicity analysis of Radiation Therapy Oncology Group 95-17. Int J Radiat Oncol Biol Phys. 2002;54(suppl):87.
23. Patel RR, Shah HK, Das RK, Forouzannia A, Odou H, Kuske RR. Interstitial high dose rate accelerated partial breast irradiation alone in breast conservation therapy. The University of Wisconsin experience, Proceedings of the 89th Scientific Assembly and Annual Meeting of the Radiologic Society of North America. 2003;147:012-RO.
24. Petereit DG, Sarkaria JN, Chappell R, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 1995;32:1301-1307.
25. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 1992;23:457-467.
26. Swift M, Morell D, Massey RB, et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 1991;325:1831-1836.
27. Finn R. Surveys identify barriers to participation in clinical trials. J Natl Cancer Inst. 2000;92:1556-1558.
28. Burhansstipanov L, Krebs LU, Bradley A, et al. Lessons learned while developing "Clinical Trials Education for Native Americans" curriculum. Cancer Control. September/October 2003;10(suppl):29-36.
29. Burhansstipanov L. Clinical trials education for Native Americans. Native American Cancer Research Web site. Available at: http://NatAmCancer.org. Accessed March 10, 2005.